Rivaroxaban Plus Aspirin Safely Benefits PAD Patients Rivaroxaban Plus Aspirin Safely Benefits PAD Patients

Results of VOYAGER-PAD show a combined regimen of rivaroxaban and aspirin was safe and reduced ischemic events in peripheral arterial disease patients after lower limb revascularization.Medscape Medical News

Source: Medscape Cardiology Headlines - March 29, 2020 Category: Cardiology Tags: Cardiology News Source Type: news